ICICI Lombard General Insurance has scheduled three in-person meetings with analysts and institutional investors in Mumbai for August 2026, providing market participants with direct access to management updates ahead of the next reporting cycle. The company disclosed the schedule on July 27, 2026, pursuant to Regulation 30 read with Schedule III and Regulation 46(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. These engagements allow investors to assess the insurer’s strategic direction and operational performance without the disclosure of unpublished price-sensitive information.

The Board of Directors has authorized these interactions as part of its ongoing investor relations strategy. The company confirmed that no unpublished price-sensitive information will be shared during any of the scheduled sessions. This compliance measure ensures adherence to SEBI’s listing obligations while maintaining transparency with stakeholders. The full schedule is available on the company’s official website for public reference.

Meeting Schedule

The upcoming engagements are structured as conferences held in-person in Mumbai. The specific dates and associated events are detailed below:

Vikas Mehra, Company Secretary at ICICI Lombard General Insurance Company Limited, signed the intimation letter submitted to both the Bombay Stock Exchange and the National Stock Exchange of India Limited. The disclosure was digitally signed on July 27, 2026, at 13:07:06 IST.

Operational Context

The selection of these conferences reflects the company’s focus on engaging with key domestic institutional players. The Nirmal Bang conference typically attracts equity analysts focused on financial services, while Emkay Confluence and the Motilal Oswal Global Investor Conference provide broader platforms for discussing sector trends and long-term growth strategies. By holding all three meetings in Mumbai, the company minimizes logistical complexity while maximizing accessibility for local investors.

What the Numbers Show

While this filing does not contain financial metrics, the timing of these meetings—mid-August—is significant. It positions the company to address investor queries following the closure of Q2FY27 and before the release of quarterly results. This window allows management to clarify operational nuances and strategic initiatives that may not be fully captured in standard financial statements. The absence of virtual options suggests a preference for direct engagement, potentially indicating a desire for more nuanced dialogue than webinars permit.

Investors should note that the schedule is subject to change due to exigencies on the part of the analysts, investors, or the company itself. Any modifications will likely be communicated through subsequent regulatory filings or website updates.

ICICI Lombard General Insurance Company Limited reported a 46% decline in net profit to ₹403.17 crore for the quarter ended June 30, 2026, compared to ₹747.08 crore in the corresponding period of the previous year. The decline was primarily attributed to the recognition of claim reserves amounting to ₹16,500 lakhs following a Supreme Court judgment on June 11, 2026, regarding compensation for unpaid domestic work under the Motor Vehicles Act. Net Premium Written increased by 17.7% to ₹6,603.73 crore from ₹5,610.52 crore in Q1FY26.

Financial Performance

The Board of Directors approved the audited financial results for Q1FY27 on July 15, 2026. The Combined Ratio deteriorated to 107.2% from 102.9% in the previous year. Excluding the impact of the Supreme Court judgment and two large losses in the Fire segment, the company stated that its Profit After Tax (PAT) would have de-grown by 23.0% to ₹5.75 billion. The Solvency Ratio stood at 2.71, slightly improving from 2.70 in the prior year.

The following table summarises the key financial metrics for Q1FY27:

Operational Metrics & Outlook

Looking ahead, the company indicated that the Combined Ratio is expected to improve to 102%-103% in FY27, in line with historical trends. The company noted that the Supreme Court judgment supports the case for a Motor Third-Party Premium hike. The financial results were audited by joint statutory auditors Walker Chandiok & Co LLP and BSR & Co LLP.

Segment Performance

Segment-wise performance varied during the quarter. The Motor segment reported an underwriting loss of ₹2,452.1 crore, while the Health Group, Corporate segment recorded a loss of ₹3,017.3 crore. The Miscellaneous Group, Corporate segment posted a profit of ₹255.9 crore. Retail Health delivered robust growth of 69.5% for Q1FY27 against industry growth of 31.6%.

Corporate Actions

The Board approved a final dividend of ₹7 per equity share of face value ₹10 each for the year ended March 31, 2026. Additionally, the tenure of Mr. Vinod Mahajan, Chief Investment Officer, was extended for two years effective from May 1, 2027, to April 30, 2029.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE765G01017/843cbb74-79bc-43cf-bdfc-2aac45d159da.pdf